Research Participant Portal is your entry point for electronic administration of EU-funded research and innovation projects
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
The overall objective of this topic is to determine whether diabetic cardiomyopathy is unique and distinct from the other forms of heart failure such as HFpEF or HCM by performing unbiased statistical clustering analysis from a dense phenotyping of these patient populations. Similar methodology has recently been used to identify phenotypically distinct and more homogeneous HFpEF segments. This approach would facilitate a molecular taxonomy of diabetic cardiomyopathy which is widely accepted in the scientific community and could be applied in the clinics for differentiation from other forms of heart muscle disorders already at disease onset, thereby enabling an optimised and individualised treatment of patients.
Furthermore, a better comprehension of the underlying mechanisms and clinical manifestations of diabetic cardiomyopathy will also allow the development of more translatable and predictable preclinical models to support target and drug discovery.
Deadline:28/02/2018